American Society of Clinical Oncology
43
12
16
21
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
9.3%
4 terminated/withdrawn out of 43 trials
84.0%
-2.5% vs industry average
2%
1 trials in Phase 3/4
52%
11 of 21 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (43)
Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer
Role: collaborator
DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
Role: collaborator
Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
Role: collaborator
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Role: lead
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer
Role: collaborator
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Role: lead
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
Role: collaborator
Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome
Role: collaborator
PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery
Role: collaborator
Ultrahypofractionation and Normal Tissue Toxicity
Role: collaborator
Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors
Role: collaborator
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
Role: collaborator
Pilot of a Trial Enrollment Diversity Dashboard
Role: collaborator
Enhanced Assistance During Radiotherapy for Unmet Essential Needs
Role: collaborator
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas
Role: collaborator
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
Role: collaborator
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
Role: collaborator
Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias
Role: collaborator
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Role: collaborator
Electronic Patient Reporting of Symptoms During Cancer Treatment
Role: collaborator